FoxP3, PD-1 and CTLA-4 are decreased significantly after a tenofovir therapy in patients with chronic hepatitis B

Cho, H; Kang, H; Kim, JY; Kim, HY; Kim, CW

Cho, H (corresponding author), Duksung Womens Univ, Dept Pharm, Coll Pharm, Seoul, South Korea.; Cho, H (corresponding author), Duksung Womens Univ, Dept Pharm, Duksung Innovat Drug Ctr, Seoul, South Korea.; Kang, H (corresponding author), Kyungpook Natl Univ, Coll Pharm, Dept Pharm, Res Inst Pharmaceut Sci, Daegu, South Korea.; Kang, H (corresponding author), Kyungpook Natl Univ, Inst Microorganisms, Daegu, South Korea.; Kim, CW (corresponding author), Catholic Univ Korea, Dept Internal Med, Coll Med, Seoul, South Korea.

FUTURE VIROLOGY, 2020; 15 (4): 235